BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23345333)

  • 1. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo.
    Piao W; Vogel SN; Toshchakov VY
    J Immunol; 2013 Mar; 190(5):2263-72. PubMed ID: 23345333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain.
    Piao W; Ru LW; Piepenbrink KH; Sundberg EJ; Vogel SN; Toshchakov VY
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19036-41. PubMed ID: 24194546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.
    Rallabhandi P; Nhu QM; Toshchakov VY; Piao W; Medvedev AE; Hollenberg MD; Fasano A; Vogel SN
    J Biol Chem; 2008 Sep; 283(36):24314-25. PubMed ID: 18622013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIF signaling is essential for TLR4-driven IgE class switching.
    Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
    J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.
    Couture LA; Piao W; Ru LW; Vogel SN; Toshchakov VY
    J Biol Chem; 2012 Jul; 287(29):24641-8. PubMed ID: 22648407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
    Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
    J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface.
    Toshchakov VY; Szmacinski H; Couture LA; Lakowicz JR; Vogel SN
    J Immunol; 2011 Apr; 186(8):4819-27. PubMed ID: 21402890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
    Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
    J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling.
    Sacre SM; Lundberg AM; Andreakos E; Taylor C; Feldmann M; Foxwell BM
    J Immunol; 2007 Feb; 178(4):2148-54. PubMed ID: 17277119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
    Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
    J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation.
    Shen H; Tesar BM; Walker WE; Goldstein DR
    J Immunol; 2008 Aug; 181(3):1849-58. PubMed ID: 18641322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
    Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
    J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
    Kadoki M; Choi BI; Iwakura Y
    Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
    Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
    Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.